Repligen Corporation · 1 day ago
Quality Control Inspector I - 2nd Shift
Clifton Park, NY
Full-time
Onsite
New Grad, Entry Level
$21/hr - $23/hrRepligen Corporation is focused on inspiring advances in bioprocessing as a preferred partner in the production of biologic drugs that improve human health worldwide. They are seeking a Quality Control Inspector I for their 2nd shift team to ensure products meet high-quality standards through inspection and collaboration with manufacturing teams.
AnalyticsBiotechnologyConsumer GoodsHealth CareManufacturingPharmaceutical
Responsibilities
Inspect products against acceptance criteria to maintain high-quality standards
Work closely with manufacturing teams to identify and resolve quality issues
Read and interpret engineering drawings, specifications, and purchase orders
Accurately document inspection results using Microsoft Office and other software
Use precision measurement tools like calipers and pin gauges
Operate in an ISO 7 cleanroom while following strict gowning procedures
Support additional quality-related functions as needed
Qualification
Required
High School Diploma or equivalent
Preferred
Bachelor's degree in science or relevant experience
Experience in Quality Assurance (QA) or Quality Control (QC)
Experience in a cleanroom environment
Medical device or medical manufacturing experience
Strong attention to detail and ability to work in a structured environment
Proficiency in basic math, measurements, and testing equipment
Benefits
Paid time off
Health/dental/vision
Retirement benefits
Flexible spending accounts
Company
Repligen Corporation
FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses.
Founded in 1981
1001-5000 employees
H1B Sponsorship
Repligen Corporation has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (2)
2023 (1)
2022 (5)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$1.34B2023-12-06Post Ipo Debt· $600M
2020-12-07Post Ipo Equity· $312.23M
2019-07-17Post Ipo Debt· $287.5M
Leadership Team
Jason Garland
Chief Financial Officer
Rachel Legmann
Senior Director of Technology, Gene Therapy
Recent News
2026-01-06
2026-01-06
Company data provided by crunchbase